Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,"GPCRs, Class A Rhodopsin-like WP455",1.1740992629615622e-05,9.276118197965445,105.30642867613233,"['P2RY12', 'CX3CR1', 'P2RY13', 'CHRM3', 'CYSLTR1', 'GPR34', 'HRH2', 'GPR65', 'OPRM1']",0.005072108815993948,0,0,9
2,Complement system WP2806,0.0004737692006863294,4.8513067749302206,37.135735913218404,"['FCGR3A', 'CD93', 'PROS1', 'ITGAX', 'SPP1', 'F13A1', 'VSIG4', 'CD55', 'TLR2']",0.06534793991621754,0,0,9
3,Endochondral Ossification with Skeletal Dysplasias WP4808,0.0006050735177427549,5.320817688777638,39.42811354600794,"['HDAC4', 'HMGCS1', 'STAT1', 'SPP1', 'ENPP1', 'PLAT', 'IGF1', 'SLC38A2']",0.06534793991621754,0,0,8
4,Endochondral Ossification WP474,0.0006050735177427549,5.320817688777638,39.42811354600794,"['HDAC4', 'HMGCS1', 'STAT1', 'SPP1', 'ENPP1', 'PLAT', 'IGF1', 'SLC38A2']",0.06534793991621754,0,0,8
5,Spinal Cord Injury WP2431,0.000972396911054463,3.5624649859943975,24.708354030009318,"['C1QB', 'GJA1', 'ZFP36', 'GAP43', 'FCGR2A', 'PTPRZ1', 'TNFSF13', 'AQP4', 'AIF1', 'TNFSF13B', 'RHOB']",0.07947292115800432,0,0,11
6,Development and heterogeneity of the ILC family WP3893,0.001287755666912107,15.002347417840376,99.83843725733499,"['IL15', 'ZBTB16', 'ID2', 'IL18']",0.07947292115800432,0,0,4
7,Differentiation of white and brown adipocyte WP2895,0.001287755666912107,15.002347417840376,99.83843725733499,"['PLAC8', 'CEBPA', 'CEBPB', 'PPARGC1B']",0.07947292115800432,0,0,4
8,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.004008174126413389,4.156963204471356,22.94402365277454,"['FADS2', 'HMGCS1', 'ACSL1', 'SCD', 'CYP51A1', 'DHCR24', 'ABCG1']",0.2077198872362313,0,0,7
9,Complement Activation WP545,0.004856484400877603,16.850615114235502,89.77064902422107,"['C1QB', 'C1QA', 'CD55']",0.2077198872362313,0,0,3
10,HIF1A and PPARG regulation of glycolysis WP2456,0.004856484400877603,16.850615114235502,89.77064902422107,"['LDHA', 'TPI1', 'HIF1A']",0.2077198872362313,0,0,3
11,Complement and Coagulation Cascades WP558,0.005498652617185759,5.62962962962963,29.292382729937316,"['C1QB', 'C1QA', 'PROS1', 'PLAT', 'CD55']",0.2077198872362313,0,0,5
12,NRF2 pathway WP2884,0.006079617504233213,3.0813822057161313,15.723718704032372,"['SLC2A9', 'SLC6A6', 'FGF13', 'SLC2A5', 'SLC6A1', 'SLC5A3', 'FTL', 'PPARD', 'HSPA1A']",0.2077198872362313,0,0,9
13,"GPCRs, Other WP117",0.00632542891848232,7.497652582159624,37.96194535798102,"['CHRM3', 'ADGRE2', 'P2RY13', 'ADGRL2']",0.2077198872362313,0,0,4
14,Monoamine GPCRs WP58,0.006731663012285274,inf,inf,"['CHRM3', 'HRH2']",0.2077198872362313,0,0,2
15,Nuclear Receptors Meta-Pathway WP2882,0.007915784487266216,2.0753075656301463,10.042198467118812,"['STAT3', 'SLC6A1', 'SLC2A5', 'SLC5A3', 'SLC2A9', 'SLC6A6', 'SCD', 'ENC1', 'PDE4B', 'BAX', 'FGF13', 'PLTP', 'CPEB4', 'PPARD', 'HSPA1A', 'FKBP5', 'FTL']",0.22797459323326702,0,0,17
16,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.009122789315351636,11.231985940246046,52.75640967881097,"['CDKN1A', 'SPP1', 'ENPP1']",0.23182617554305335,0,0,3
17,Genes targeted by miRNAs in adipocytes WP1992,0.009122789315351636,11.231985940246046,52.75640967881097,"['HDAC4', 'GJA1', 'IGF1']",0.23182617554305335,0,0,3
18,PPAR signaling pathway WP3942,0.011167614178379371,3.7550058892815077,16.8777649595154,"['FADS2', 'ACSL1', 'SCD', 'OLR1', 'PLTP', 'PPARD']",0.25460873847102955,0,0,6
19,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.011198069516086947,3.28834808259587,14.771305229859845,"['RYR2', 'GJA1', 'CACNB4', 'CACNA2D3', 'CTNNA3', 'CACNA1C', 'CACNG3']",0.25460873847102955,0,0,7
20,Lung fibrosis WP3624,0.012770610969405826,4.328449328449328,18.87467408466149,"['CEBPB', 'FAM13A', 'SPP1', 'ATP11A', 'IGF1']",0.27584519693916587,0,0,5
21,Development of pulmonary dendritic cells and macrophage subsets WP3892,0.01499908322336851,8.422671353251317,35.373250447846715,"['ID2', 'STAT3', 'TCF4']",0.2945274523861453,0,0,3
22,IL-10 Anti-inflammatory Signaling Pathway  WP4495,0.01499908322336851,8.422671353251317,35.373250447846715,"['IL10RB', 'STAT1', 'STAT3']",0.2945274523861453,0,0,3
23,TYROBP causal network in microglia WP3945,0.01678284145334151,2.539342806394316,10.379305359667201,"['IGSF6', 'ADAP2', 'DPYD', 'ITGAX', 'IL18', 'SPP1', 'HCLS1', 'TCIRG1', 'TNFRSF1B']",0.2945791750095067,0,0,9
24,IL-9 signaling pathway WP22,0.017664547891678047,4.996087636932708,20.16518689718426,"['STAT1', 'STAT3', 'GRB2', 'JAK3']",0.2945791750095067,0,0,4
25,Notch Signaling Pathway Netpath WP61,0.018503481042931355,2.9215994755817767,11.656587070256375,"['CDKN1A', 'NOTCH1', 'FHL1', 'STAT3', 'RBPJ', 'HIF1A', 'SAP30']",0.2945791750095067,0,0,7
26,LncRNA-mediated mechanisms of therapeutic resistance WP3672,0.0190930946765421,22.431578947368422,88.79380240478643,"['CDKN1A', 'HIF1A']",0.2945791750095067,0,0,2
27,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.0190930946765421,22.431578947368422,88.79380240478643,"['STAT3', 'BAX']",0.2945791750095067,0,0,2
28,miR-517 relationship with ARCN1 and USP1 WP3596,0.0190930946765421,22.431578947368422,88.79380240478643,"['CDKN1A', 'ID2']",0.2945791750095067,0,0,2
29,IL-4 signaling pathway WP395,0.02154515475549461,2.8168141592920355,10.80981820054463,"['CEBPA', 'CEBPB', 'IL4R', 'STAT1', 'STAT3', 'GRB2', 'JAK3']",0.2952424422900935,0,0,7
30,Acute viral myocarditis WP4298,0.021897628286708805,2.57710233029382,9.848079431011172,"['STAT1', 'STAT3', 'CASP1', 'CYCS', 'BAX', 'TLR5', 'AIF1', 'CD55']",0.2952424422900935,0,0,8
31,Cori Cycle WP1946,0.02255324211938214,6.737082601054482,25.546184847700445,"['LDHA', 'TPI1', 'PGAM1']",0.2952424422900935,0,0,3
32,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.02255324211938214,6.737082601054482,25.546184847700445,"['RAB27A', 'MYRIP', 'UNC13D']",0.2952424422900935,0,0,3
33,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.02255324211938214,6.737082601054482,25.546184847700445,"['CYSLTR1', 'LTC4S', 'PPARD']",0.2952424422900935,0,0,3
34,Oxidative Damage WP3941,0.024727211014682737,3.51521164021164,13.005759236223746,"['C1QB', 'C1QA', 'CDKN1A', 'CYCS', 'TNFRSF1B']",0.30520443309551265,0,0,5
35,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.024727211014682737,3.51521164021164,13.005759236223746,"['IFNAR2', 'OAS1', 'STAT1', 'IKBKE', 'TLR2']",0.30520443309551265,0,0,5
36,Adipogenesis WP236,0.02706778636264651,2.3070402066849667,8.32705619162034,"['CEBPA', 'CDKN1A', 'CEBPB', 'STAT1', 'SCD', 'STAT3', 'IGF1', 'HIF1A', 'PPARD']",0.32481343635175813,0,0,9
37,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.02894888816394141,2.069934640522876,7.332171087984335,"['RYR2', 'SNAP25', 'GJA1', 'CEBPB', 'AQP4', 'TPPP', 'YBX1', 'HIF1A', 'PPARGC1B', 'YWHAG', 'YWHAH']",0.3362956370035026,0,0,11
38,Immune response to tuberculosis WP4197,0.029581560662345137,4.0864276568501925,14.386693809258949,"['IFNAR2', 'OAS1', 'STAT1', 'PTPN2']",0.3362956370035026,0,0,4
39,Omega-9 FA synthesis WP4724,0.03180179359740695,5.61335676625659,19.35615973145432,"['FADS2', 'ACSL1', 'SCD']",0.34146401948205507,0,0,3
40,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.03565222102309108,2.3113293326059283,7.705842175107947,"['TUBB2B', 'HSPA5', 'PSMD5', 'CASP1', 'STUB1', 'TUBB4A', 'HSPA1B', 'HSPA1A']",0.34146401948205507,0,0,8
41,Neural Crest Differentiation WP2064,0.03571552467080417,3.123652753282383,10.408541432629965,"['HDAC4', 'NOTCH1', 'TCF4', 'RBPJ', 'RHOB']",0.34146401948205507,0,0,5
42,Cholesterol Biosynthesis with Skeletal Dysplasias WP4804,0.03611739257244094,11.214035087719298,37.241594554719974,"['CYP51A1', 'DHCR24']",0.34146401948205507,0,0,2
43,"GPCRs, Class B Secretin-like WP334",0.03611739257244094,11.214035087719298,37.241594554719974,"['ADGRE2', 'ADGRL2']",0.34146401948205507,0,0,2
44,Inflammatory Response Pathway WP453,0.03611739257244094,11.214035087719298,37.241594554719974,"['IL4R', 'TNFRSF1B']",0.34146401948205507,0,0,2
45,PTF1A related regulatory pathway WP4147,0.03611739257244094,11.214035087719298,37.241594554719974,"['NOTCH1', 'RBPJ']",0.34146401948205507,0,0,2
46,Photodynamic therapy-induced unfolded protein response WP3613,0.03695323305158211,3.745305164319249,12.352398967666335,"['DNAJC3', 'XBP1', 'WARS', 'HSPA5']",0.34146401948205507,0,0,4
47,Synaptic Vesicle Pathway WP2267,0.03715002063809395,2.4631637168141594,8.110683200720793,"['SNAP25', 'SLC38A1', 'RAB3A', 'CACNA1A', 'SYN3', 'CPLX1', 'STX1A']",0.34146401948205507,0,0,7
48,Vitamin D Receptor Pathway WP2877,0.039835341911374826,2.253191489361702,7.262037911922157,"['CEBPA', 'CDKN1A', 'DUSP10', 'BCL6', 'SATB1', 'SPP1', 'HIF1A', 'PPARD']",0.35851807720237344,0,0,8
49,Toll-like Receptor Signaling Pathway WP75,0.04114794672189767,2.113454706927176,6.743148961715963,"['IFNAR2', 'STAT1', 'SPP1', 'LY96', 'MAP3K8', 'TLR5', 'IKBKE', 'MAP2K6', 'TLR2']",0.36277373436448557,0,0,9
50,Development of ureteric collection system WP5053,0.042720253815680426,4.810695455686668,15.168517936590446,"['ROBO2', 'GRIP1', 'SALL1']",0.3691029929674789,0,0,3
51,Allograft Rejection WP2328,0.049182019167181096,2.4998036906164116,7.529976637447398,"['C1QB', 'C1QA', 'CXCL12', 'STAT1', 'LRRK2', 'CD55']",0.4095221761569265,0,0,6
52,Glycolysis and Gluconeogenesis WP534,0.049294336018889294,2.810405643738977,8.459169485961125,"['LDHA', 'TPI1', 'PGAM1', 'ALDOC', 'SLC2A5']",0.4095221761569265,0,0,5
53,Oncostatin M Signaling Pathway WP2374,0.05278971324460687,2.2509734513274338,6.621100945000974,"['CEBPB', 'STAT1', 'PXN', 'STAT3', 'GRB2', 'JAK3', 'HIF1A']",0.4302859645598145,0,0,7
54,GDNF/RET signaling axis WP4830,0.05695803691205933,7.474853801169591,21.418748640012204,"['ROBO2', 'SALL1']",0.4473794899274478,0,0,2
55,NOTCH1 regulation of endothelial cell calcification WP3413,0.05695803691205933,7.474853801169591,21.418748640012204,"['NOTCH1', 'PLAT']",0.4473794899274478,0,0,2
56,Apoptosis Modulation and Signaling WP1772,0.06520766508613829,2.1286295144702225,5.8115380118436,"['CAPNS1', 'CASP4', 'CASP1', 'CYCS', 'BAX', 'TNFRSF1B', 'HSPA1A']",0.47936165578375045,0,0,7
57,Calcium Regulation in the Cardiac Cell WP536,0.06586731855337292,1.7714285714285714,4.818485682566993,"['RGS4', 'CHRM3', 'RYR2', 'GJA1', 'GNG3', 'PKIA', 'CACNA1A', 'CALM3', 'CACNA1C', 'YWHAG', 'YWHAH']",0.47936165578375045,0,0,11
58,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.06931535071936881,3.740480374926772,9.983674597819515,"['STAT3', 'SPP1', 'IGF1']",0.47936165578375045,0,0,3
59,Monoamine Transport WP727,0.06931535071936881,3.740480374926772,9.983674597819515,"['SLC6A1', 'NECTIN2', 'STX1A']",0.47936165578375045,0,0,3
60,Statin inhibition of cholesterol production WP430,0.06931535071936881,3.740480374926772,9.983674597819515,"['LIPC', 'APOC1', 'PLTP']",0.47936165578375045,0,0,3
61,Regulatory circuits of the STAT3 signaling pathway WP4538,0.07041755786693239,2.248763250883392,5.966671970067581,"['PTPRT', 'IFNAR2', 'IL10RB', 'STAT3', 'JAK3', 'CSF2RA']",0.47936165578375045,0,0,6
62,Ferroptosis WP4313,0.07462768683897632,2.442680776014109,6.339351903306075,"['STEAP3', 'ACSL1', 'PCBP1', 'VDAC2', 'FTL']",0.47936165578375045,0,0,5
63,Exercise-induced Circadian Regulation WP410,0.07850487760779994,2.175880542573806,5.536733706968306,"['CEBPB', 'BTG1', 'SUMO3', 'NR1D2', 'ERC2', 'ARNTL']",0.47936165578375045,0,0,6
64,Non-small cell lung cancer WP4255,0.07924936340304796,2.0188336737009305,5.1180580970354885,"['CDKN1A', 'STAT3', 'CYCS', 'BAX', 'E2F3', 'GRB2', 'JAK3']",0.47936165578375045,0,0,7
65,Glial Cell Differentiation WP2276,0.08087569251557002,5.605263157894737,14.096351005421969,"['GAP43', 'TPPP']",0.47936165578375045,0,0,2
66,Macrophage markers WP4146,0.08087569251557002,5.605263157894737,14.096351005421969,"['CD163', 'CD83']",0.47936165578375045,0,0,2
67,Nuclear Receptors in Lipid Metabolism and Toxicity WP299,0.08087569251557002,5.605263157894737,14.096351005421969,"['ABCG1', 'PPARD']",0.47936165578375045,0,0,2
68,Pyrimidine metabolism and related diseases WP4225,0.08087569251557002,5.605263157894737,14.096351005421969,"['DPYD', 'TYMP']",0.47936165578375045,0,0,2
69,Transcriptional cascade regulating adipogenesis WP4211,0.08087569251557002,5.605263157894737,14.096351005421969,"['CEBPA', 'CEBPB']",0.47936165578375045,0,0,2
70,Myometrial relaxation and contraction pathways WP289,0.08112571697196125,1.6978243352135374,4.2645192149361435,"['RGS4', 'RYR2', 'GJA1', 'GNG3', 'PKIA', 'PDE4D', 'PDE4B', 'CALM3', 'RAMP1', 'YWHAG', 'YWHAH']",0.47936165578375045,0,0,11
71,"COVID-19, thrombosis and anticoagulation WP4927",0.08211287622221651,inf,inf,['F13A1'],0.47936165578375045,0,0,1
72,Gastric acid production WP2596,0.08211287622221651,inf,inf,['CCK'],0.47936165578375045,0,0,1
73,SCFA and skeletal muscle substrate metabolism WP4030,0.08211287622221651,inf,inf,['PPARD'],0.47936165578375045,0,0,1
74,Secretion of Hydrochloric Acid in Parietal Cells WP2597,0.08211287622221651,inf,inf,['HRH2'],0.47936165578375045,0,0,1
75,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.08438184197516754,2.340534979423868,5.786745805377868,"['CEBPA', 'CDKN1A', 'CEBPB', 'NOTCH1', 'SPP1']",0.4820813394185992,0,0,5
76,SARS coronavirus and innate immunity WP4912,0.08481060600882764,3.3659050966608084,8.304814351510627,"['IFNAR2', 'STAT1', 'IKBKE']",0.4820813394185992,0,0,3
77,Hematopoietic Stem Cell Differentiation WP2849,0.10094693394095129,2.4945226917057903,5.720340420883153,"['NOTCH1', 'PIM1', 'RHOH', 'RUNX1']",0.5449622142870963,0,0,4
78,Ectoderm Differentiation WP2858,0.1026199146443829,1.7164403769154348,3.907859739508017,"['PLCXD3', 'ZBTB16', 'ARHGDIG', 'PIM1', 'SORCS1', 'LDB2', 'LY6E', 'ASTN1', 'PPARD']",0.5449622142870963,0,0,9
79,Regulation of toll-like receptor signaling pathway WP1449,0.10411255825758546,1.6553276114716349,3.7448189754860377,"['IFNAR2', 'STAT1', 'SPP1', 'LY96', 'MAP3K8', 'SMAD6', 'TLR5', 'IKBKE', 'MAP2K6', 'TLR2']",0.5449622142870963,0,0,10
80,7-oxo-C and 7beta-HC pathways WP5064,0.1072263616074148,4.4835087719298246,10.010837344372218,"['DBP', 'ACOT7']",0.5449622142870963,0,0,2
81,Biomarkers for pyrimidine metabolism disorders WP4584,0.1072263616074148,4.4835087719298246,10.010837344372218,"['DPYD', 'TYMP']",0.5449622142870963,0,0,2
82,Cell Differentiation - Index expanded WP2023,0.1072263616074148,4.4835087719298246,10.010837344372218,"['ID2', 'STAT3']",0.5449622142870963,0,0,2
83,Dual hijack model of Vif in HIV infection WP3300,0.1072263616074148,4.4835087719298246,10.010837344372218,"['ELOC', 'RUNX1']",0.5449622142870963,0,0,2
84,Nanomaterial induced apoptosis WP2507,0.1072263616074148,4.4835087719298246,10.010837344372218,"['BAX', 'CYCS']",0.5449622142870963,0,0,2
85,Type III interferon signaling WP2113,0.1072263616074148,4.4835087719298246,10.010837344372218,"['IL10RB', 'STAT1']",0.5449622142870963,0,0,2
86,MAPK Signaling Pathway WP382,0.11178355471686846,1.4703770197486534,3.2218766344295946,"['DUSP3', 'LRRK2', 'CACNA2D3', 'CACNA1A', 'CACNA1C', 'RPS6KA5', 'CACNB4', 'DUSP10', 'GRB2', 'MAP3K8', 'FGF13', 'CACNG3', 'HSPA1B', 'HSPA1A', 'MAP2K6']",0.5615173911358974,0,0,15
87,Integrated Cancer Pathway WP1971,0.11467986973503251,2.3628613787991104,5.11703805908212,"['CDKN1A', 'STAT1', 'BAX', 'BACH1']",0.5683488346107631,0,0,4
88,Apoptosis WP254,0.1157747626058962,1.9259969712266531,4.152658781721514,"['CASP4', 'CASP1', 'CYCS', 'BAX', 'IGF1', 'TNFRSF1B']",0.5683488346107631,0,0,6
89,Overview of interferons-mediated signaling pathway WP4558,0.11963533630612055,2.804042179261863,5.953842463340492,"['IFNAR2', 'STAT1', 'IL10RB']",0.580701857126338,0,0,3
90,Disruption of postsynaptic signaling by CNV WP4875,0.12918074860555812,2.2443661971830986,4.593191264460984,"['RYR2', 'GRIN2B', 'YWHAG', 'STX1A']",0.6095283947993649,0,0,4
91,Hepatitis C and Hepatocellular Carcinoma WP3646,0.12918074860555812,2.2443661971830986,4.593191264460984,"['CDKN1A', 'STAT3', 'GRB2', 'HIF1A']",0.6095283947993649,0,0,4
92,Hepatitis B infection WP4666,0.13173193840080855,1.5282014040183975,3.0976431428520805,"['CDKN1A', 'STAT1', 'STAT3', 'CYCS', 'BAX', 'GRB2', 'IKBKE', 'JAK3', 'MAP2K6', 'CREB5', 'TLR2']",0.6095283947993649,0,0,11
93,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.13545075439985887,3.7356725146198833,7.468159026883946,"['RYR2', 'CCK']",0.6095283947993649,0,0,2
94,Fluoropyrimidine Activity WP1601,0.13545075439985887,3.7356725146198833,7.468159026883946,"['DPYD', 'TYMP']",0.6095283947993649,0,0,2
95,ncRNAs involved in STAT3 signaling in hepatocellular carcinoma WP4337,0.13545075439985887,3.7356725146198833,7.468159026883946,"['STAT3', 'JAK3']",0.6095283947993649,0,0,2
96,Omega-3/Omega-6 FA synthesis WP4723,0.13545075439985887,3.7356725146198833,7.468159026883946,"['FADS2', 'ACSL1']",0.6095283947993649,0,0,2
97,Bladder cancer WP2828,0.13871583117328065,2.5879410571853456,5.112031962889283,"['CDKN1A', 'RPS6KA5', 'TYMP']",0.6114820312944615,0,0,3
98,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.13871583117328065,2.5879410571853456,5.112031962889283,"['CEBPA', 'PTPN1', 'CEBPB']",0.6114820312944615,0,0,3
99,p38 MAPK Signaling Pathway WP400,0.14439721400794892,2.1371562709590877,4.135797772590021,"['RPS6KA5', 'STAT1', 'GRB2', 'MAP2K6']",0.6300969338528679,0,0,4
100,Blood Clotting Cascade WP272,0.15749416081549894,11.196147110332749,20.69458767690614,['PLAT'],0.6337153795453864,0,0,1
101,Dopaminergic Neurogenesis WP2855,0.15749416081549894,11.196147110332749,20.69458767690614,['STAT3'],0.6337153795453864,0,0,1
102,Gene regulatory network modelling somitogenesis  WP2854,0.15749416081549894,11.196147110332749,20.69458767690614,['NOTCH1'],0.6337153795453864,0,0,1
103,Hfe effect on hepcidin production WP3924,0.15749416081549894,11.196147110332749,20.69458767690614,['HAMP'],0.6337153795453864,0,0,1
104,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.15749416081549894,11.196147110332749,20.69458767690614,['NOTCH1'],0.6337153795453864,0,0,1
105,Neovascularisation processes WP4331,0.1587368228583628,2.402711523976902,4.422208941274033,"['NOTCH1', 'CXCL12', 'HIF1A']",0.6337153795453864,0,0,3
106,Cholesterol Biosynthesis Pathway WP197,0.16506475771581772,3.2015037593984963,5.767244613796757,"['HMGCS1', 'CYP51A1']",0.6337153795453864,0,0,2
107,Computational Model of Aerobic Glycolysis WP4629,0.16506475771581772,3.2015037593984963,5.767244613796757,"['LDHA', 'TPI1']",0.6337153795453864,0,0,2
108,Glycolysis in senescence WP5049,0.16506475771581772,3.2015037593984963,5.767244613796757,"['LDHA', 'ALDOC']",0.6337153795453864,0,0,2
109,Oxysterols derived from cholesterol WP4545,0.16506475771581772,3.2015037593984963,5.767244613796757,"['DBP', 'ACOT7']",0.6337153795453864,0,0,2
110,Peptide GPCRs WP24,0.16506475771581772,3.2015037593984963,5.767244613796757,"['CX3CR1', 'OPRM1']",0.6337153795453864,0,0,2
111,TP53 network WP1742,0.16506475771581772,3.2015037593984963,5.767244613796757,"['CDKN1A', 'BAX']",0.6337153795453864,0,0,2
112,Triacylglyceride synthesis WP325,0.16506475771581772,3.2015037593984963,5.767244613796757,"['LIPC', 'PLPP3']",0.6337153795453864,0,0,2
113,Chemokine signaling pathway WP3929,0.16576351363108485,1.479209589810826,2.6584253023383213,"['CX3CR1', 'PREX1', 'GNG10', 'GNG3', 'CXCL12', 'STAT1', 'PXN', 'STAT3', 'GRB2', 'JAK3']",0.6337153795453864,0,0,10
114,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.17150280486455158,1.3698924731182796,2.4153336643020658,"['IFNAR2', 'CDKN1A', 'IL4R', 'IGF1', 'HIF1A', 'GNG10', 'GNG3', 'PIK3IP1', 'SPP1', 'ITGAX', 'GRB2', 'FGF13', 'JAK3', 'CREB5']",0.6499053658025112,0,0,14
115,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.17675204515058265,1.9507042253521127,3.3805848643911625,"['IFNAR2', 'OAS1', 'STAT1', 'IKBKE']",0.6552029928292521,0,0,4
116,EPO Receptor Signaling WP581,0.17956933614619405,2.2421792618629173,3.850256488045285,"['STAT1', 'STAT3', 'GRB2']",0.6552029928292521,0,0,3
117,Fatty acid beta-oxidation WP143,0.17956933614619405,2.2421792618629173,3.850256488045285,"['LIPC', 'TPI1', 'ACSL1']",0.6552029928292521,0,0,3
118,IL-7 signaling pathway WP205,0.17956933614619405,2.2421792618629173,3.850256488045285,"['STAT1', 'STAT3', 'JAK3']",0.6552029928292521,0,0,3
119,Apoptosis Modulation by HSP70 WP384,0.1956508936920683,2.800877192982456,4.569416488197638,"['CYCS', 'HSPA1A']",0.6552029928292521,0,0,2
120,Canonical and non-canonical Notch signaling WP3845,0.1956508936920683,2.800877192982456,4.569416488197638,"['NOTCH1', 'RBPJ']",0.6552029928292521,0,0,2
121,Cardiac Progenitor Differentiation WP2406,0.1956508936920683,2.800877192982456,4.569416488197638,"['NOTCH1', 'IGF1']",0.6552029928292521,0,0,2
122,Differentiation Pathway WP2848,0.1956508936920683,2.800877192982456,4.569416488197638,"['NOTCH1', 'IGF1']",0.6552029928292521,0,0,2
123,Eicosanoid Synthesis WP167,0.1956508936920683,2.800877192982456,4.569416488197638,"['PTGES2', 'LTC4S']",0.6552029928292521,0,0,2
124,IL1 and megakaryocytes in obesity WP2865,0.1956508936920683,2.800877192982456,4.569416488197638,"['IL18', 'TLR2']",0.6552029928292521,0,0,2
125,Iron metabolism in placenta WP2007,0.1956508936920683,2.800877192982456,4.569416488197638,"['STEAP3', 'HAMP']",0.6552029928292521,0,0,2
126,Sleep regulation WP3591,0.1956508936920683,2.800877192982456,4.569416488197638,"['PER3', 'IL18']",0.6552029928292521,0,0,2
127,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.1956508936920683,2.800877192982456,4.569416488197638,"['HMGCS1', 'SCD']",0.6552029928292521,0,0,2
128,Tryptophan metabolism WP465,0.1956508936920683,2.800877192982456,4.569416488197638,"['WARS', 'DHCR24']",0.6552029928292521,0,0,2
129,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.1956508936920683,2.800877192982456,4.569416488197638,"['ZBTB16', 'PPARD']",0.6552029928292521,0,0,2
130,Nanoparticle triggered autophagic cell death WP2509,0.2010865990225502,2.101713532513181,3.371189747655755,"['VMP1', 'ATG3', 'ATG14']",0.6581015968010734,0,0,3
131,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.2010865990225502,2.101713532513181,3.371189747655755,"['LDHA', 'BAX', 'HIF1A']",0.6581015968010734,0,0,3
132,The influence of laminopathies on Wnt signaling WP4844,0.2010865990225502,2.101713532513181,3.371189747655755,"['CEBPA', 'CEBPB', 'SPP1']",0.6581015968010734,0,0,3
133,3q29 copy number variation syndrome WP4906,0.21302321255155265,1.6495487083722378,2.550786474480155,"['DYNLT3', 'PXN', 'HIF1A', 'HAMP', 'PIGX']",0.6712293814843244,0,0,5
134,Parkinson's disease pathway WP2371,0.22316557648799226,1.977773183086943,2.966345877449569,"['PINK1', 'LRRK2', 'CYCS']",0.6712293814843244,0,0,3
135,Toll-like Receptor Signaling related to MyD88 WP3858,0.22316557648799226,1.977773183086943,2.966345877449569,"['TLR5', 'IKBKE', 'TLR2']",0.6712293814843244,0,0,3
136,EV release from cardiac cells and their functional effects WP3297,0.2266947225834707,5.5971978984238175,8.307086863943294,['CXCL12'],0.6712293814843244,0,0,1
137,Folate-Alcohol and Cancer Pathway Hypotheses WP1589,0.2266947225834707,5.5971978984238175,8.307086863943294,['CEBPB'],0.6712293814843244,0,0,1
138,Linoleic acid metabolism known to be affected by coronavirus infection WP4853,0.2266947225834707,5.5971978984238175,8.307086863943294,['FADS2'],0.6712293814843244,0,0,1
139,Liver X receptor pathway WP2874,0.2266947225834707,5.5971978984238175,8.307086863943294,['SCD'],0.6712293814843244,0,0,1
140,Metabolism of alpha-linolenic acid WP4586,0.2266947225834707,5.5971978984238175,8.307086863943294,['FADS2'],0.6712293814843244,0,0,1
141,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.2266947225834707,5.5971978984238175,8.307086863943294,['HIF1A'],0.6712293814843244,0,0,1
142,Peroxiredoxin 2 induced ovarian failure WP4873,0.2266947225834707,5.5971978984238175,8.307086863943294,['BAX'],0.6712293814843244,0,0,1
143,Sulfation Biotransformation Reaction WP692,0.2266947225834707,5.5971978984238175,8.307086863943294,['SULT4A1'],0.6712293814843244,0,0,1
144,Gastric Cancer Network 2 WP2363,0.2268506705942393,2.4892787524366473,3.692753714438602,"['PLAC8', 'RNF144B']",0.6712293814843244,0,0,2
145,Genes controlling nephrogenesis WP4823,0.2268506705942393,2.4892787524366473,3.692753714438602,"['ROBO2', 'CXCL12']",0.6712293814843244,0,0,2
146,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.2268506705942393,2.4892787524366473,3.692753714438602,"['IL4R', 'STAT3']",0.6712293814843244,0,0,2
147,TGF-beta Receptor Signaling WP560,0.22919894106077568,1.7248104008667389,2.5409301663867905,"['STAT1', 'STAT3', 'SPP1', 'SMAD6']",0.6735642349541163,0,0,4
148,7q11.23 copy number variation syndrome WP4932,0.23196325179969185,1.4546050475254015,2.125434446435911,"['GRIP1', 'SNAP25', 'VPS9D1', 'ATP5MC3', 'GRB2', 'STX1A', 'ATP5MC1']",0.6770819241720735,0,0,7
149,Melanoma WP4685,0.2439852360023093,1.5574172055653537,2.196966786705953,"['CDKN1A', 'BAX', 'E2F3', 'CALM3', 'GRB2']",0.7073934359261586,0,0,5
150,IL-2 signaling pathway WP49,0.24748318833309635,1.6606677099634846,2.3189773564671805,"['STAT1', 'STAT3', 'GRB2', 'JAK3']",0.7095819670109718,0,0,4
151,Prolactin Signaling Pathway WP2037,0.25242623828361443,1.4628975265017667,2.013877689756224,"['PTPN1', 'STAT1', 'PXN', 'STAT3', 'GRB2', 'YWHAG']",0.7095819670109718,0,0,6
152,TNF-alpha signaling pathway WP231,0.25734222310697014,1.402212389380531,1.9032908448037331,"['BAX', 'MAP3K8', 'GRB2', 'PYGL', 'KSR2', 'TNFRSF1B', 'MAP2K6']",0.7095819670109718,0,0,7
153,Fatty Acid Biosynthesis WP357,0.25835773716343524,2.24,3.0316385709556104,"['ACSL1', 'SCD']",0.7095819670109718,0,0,2
154,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.25835773716343524,2.24,3.0316385709556104,"['CDKN1A', 'STAT1']",0.7095819670109718,0,0,2
155,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.25835773716343524,2.24,3.0316385709556104,"['LDHA', 'HIF1A']",0.7095819670109718,0,0,2
156,Purinergic signaling WP4900,0.25835773716343524,2.24,3.0316385709556104,"['P2RY12', 'P2RY13']",0.7095819670109718,0,0,2
157,Interferon type I signaling pathways WP585,0.259892392734712,1.5150865150865152,2.041560303723052,"['IFNAR2', 'RPS6KA5', 'STAT1', 'STAT3', 'MAP2K6']",0.7095819670109718,0,0,5
158,Pathogenic Escherichia coli infection WP2272,0.259892392734712,1.5150865150865152,2.041560303723052,"['TUBB2B', 'HCLS1', 'LY96', 'TLR5', 'TUBB4A']",0.7095819670109718,0,0,5
159,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.2685420323446792,1.7690315419480158,2.3258303849399042,"['CASP1', 'IL18', 'NLRP1']",0.7095819670109718,0,0,3
160,Type 2 papillary renal cell carcinoma WP4241,0.2685420323446792,1.7690315419480158,2.3258303849399042,"['CDKN1A', 'ELOC', 'HIF1A']",0.7095819670109718,0,0,3
161,PI3K-Akt signaling pathway WP4172,0.2686500572933243,1.2476644802226198,1.639862380422904,"['IFNAR2', 'CDKN1A', 'IL4R', 'IGF1', 'GNG10', 'GNG3', 'SPP1', 'GRB2', 'FGF13', 'PIK3AP1', 'JAK3', 'TLR2', 'CREB5']",0.7095819670109718,0,0,13
162,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.2848964598681603,1.5456532297231667,1.9407677354871657,"['STAT1', 'STAT3', 'SPP1', 'SMAD6']",0.7095819670109718,0,0,4
163,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.2899117606039049,2.0360446570972885,2.520987077968376,"['TLR5', 'TLR2']",0.7095819670109718,0,0,2
164,Sphingolipid Metabolism (general overview) WP4725,0.2899117606039049,2.0360446570972885,2.520987077968376,"['UGCG', 'PLPP3']",0.7095819670109718,0,0,2
165,Transcription factor regulation in adipogenesis WP3599,0.2899117606039049,2.0360446570972885,2.520987077968376,"['CEBPA', 'CEBPB']",0.7095819670109718,0,0,2
166,Caloric restriction and aging WP4191,0.2902205055853743,3.730881494454174,4.615526776927506,['IGF1'],0.7095819670109718,0,0,1
167,Cysteine and methionine catabolism WP4504,0.2902205055853743,3.730881494454174,4.615526776927506,['SQOR'],0.7095819670109718,0,0,1
168,Farnesoid X receptor pathway WP2879,0.2902205055853743,3.730881494454174,4.615526776927506,['FKBP5'],0.7095819670109718,0,0,1
169,Glutathione metabolism WP100,0.2902205055853743,3.730881494454174,4.615526776927506,['IDH1'],0.7095819670109718,0,0,1
170,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.2902205055853743,3.730881494454174,4.615526776927506,['LIPC'],0.7095819670109718,0,0,1
171,Metastatic brain tumor WP2249,0.2902205055853743,3.730881494454174,4.615526776927506,['E2F3'],0.7095819670109718,0,0,1
172,Mevalonate pathway WP3963,0.2902205055853743,3.730881494454174,4.615526776927506,['HMGCS1'],0.7095819670109718,0,0,1
173,Role of Osx and miRNAs in tooth development WP3971,0.2902205055853743,3.730881494454174,4.615526776927506,['NOTCH1'],0.7095819670109718,0,0,1
174,Serotonin Transporter Activity WP1455,0.2902205055853743,3.730881494454174,4.615526776927506,['STX1A'],0.7095819670109718,0,0,1
175,TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer WP2868,0.2902205055853743,3.730881494454174,4.615526776927506,['STAT3'],0.7095819670109718,0,0,1
176,Thiamine metabolic pathways WP4297,0.2902205055853743,3.730881494454174,4.615526776927506,['SLC25A19'],0.7095819670109718,0,0,1
177,Vitamin D-sensitive calcium signaling in depression WP4698,0.2916213554613191,1.680316344463972,2.0706522283706534,"['ATP2B4', 'CACNA1C', 'GRIN2B']",0.7095819670109718,0,0,3
178,MECP2 and Associated Rett Syndrome WP3584,0.29237405122211335,1.4369375480486593,1.7670327083908892,"['RBFOX1', 'BCL6', 'YBX1', 'IGF1', 'FKBP5']",0.7095819670109718,0,0,5
179,ESC Pluripotency Pathways WP3931,0.30887555426810365,1.4007936507936507,1.6456759425833496,"['STAT3', 'GRB2', 'SMAD6', 'FGF13', 'MAP2K6']",0.7384132558082072,0,0,5
180,IL-18 signaling pathway WP4754,0.30899858218499887,1.212934362934363,1.4244926648778755,"['CEBPB', 'NRN1', 'CD83', 'GRM7', 'PTPRZ1', 'IL18', 'SPP1', 'TNFAIP2', 'CYCS', 'BAX', 'GRIN2B', 'CDK5R2']",0.7384132558082072,0,0,12
181,Senescence and Autophagy in Cancer WP615,0.3104535512829549,1.345017667844523,1.5732953873600437,"['ATG3', 'CDKN1A', 'CEBPB', 'PLAT', 'IGF1', 'ATG14']",0.7384132558082072,0,0,6
182,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.31482715395123667,1.6000502134069796,1.8492284466121574,"['SLC12A5', 'STAT3', 'GABRG2']",0.7384132558082072,0,0,3
183,PDGFR-beta pathway WP3972,0.31482715395123667,1.6000502134069796,1.8492284466121574,"['STAT1', 'STAT3', 'GRB2']",0.7384132558082072,0,0,3
184,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.31482715395123667,1.6000502134069796,1.8492284466121574,"['CDKN1A', 'BAX', 'MAP2K6']",0.7384132558082072,0,0,3
185,Sphingolipid Metabolism (integrated pathway) WP4726,0.32129295559894483,1.8660818713450293,2.118752972790496,"['UGCG', 'PLPP3']",0.7384132558082072,0,0,2
186,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.32129295559894483,1.8660818713450293,2.118752972790496,"['FCGR2A', 'IKBKE']",0.7384132558082072,0,0,2
187,White fat cell differentiation WP4149,0.32129295559894483,1.8660818713450293,2.118752972790496,"['CEBPA', 'CEBPB']",0.7384132558082072,0,0,2
188,Endometrial cancer WP4155,0.32305579941609064,1.4454793275783735,1.6332907703800768,"['CDKN1A', 'BAX', 'CTNNA3', 'GRB2']",0.7384132558082072,0,0,4
189,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.32305579941609064,1.4454793275783735,1.6332907703800768,"['PXN', 'STAT3', 'BAX', 'GRB2']",0.7384132558082072,0,0,4
190,Breast cancer pathway WP4262,0.3253225438015946,1.3184369154022033,1.4805231058366242,"['CDKN1A', 'NOTCH1', 'BAX', 'GRB2', 'E2F3', 'IGF1']",0.7396807311699414,0,0,6
191,Metabolic reprogramming in colon cancer WP4290,0.3380675966277752,1.5270810033551685,1.6561337232721125,"['LDHA', 'PGAM1', 'SLC16A3']",0.7453841700990201,0,0,3
192,NO/cGMP/PKG mediated Neuroprotection WP4008,0.3380675966277752,1.5270810033551685,1.6561337232721125,"['TSPO', 'CYCS', 'GRIN2B']",0.7453841700990201,0,0,3
193,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.34028602295075594,1.2928784995922804,1.393682647317943,"['NOTCH1', 'ID2', 'GRB2', 'RBPJ', 'HIF1A', 'MAP2K6']",0.7453841700990201,0,0,6
194,Alzheimer's disease WP2059,0.3422222507292322,1.3336692701772066,1.4300867527647971,"['VMP1', 'CYCS', 'CALM3', 'CACNA1C', 'GRIN2B']",0.7453841700990201,0,0,5
195,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.34227993442002297,1.400088028169014,1.5010712743616446,"['CDKN1A', 'GRB2', 'PFN1', 'PFN2']",0.7453841700990201,0,0,4
196,Activation of NLRP3 Inflammasome by SARS-CoV-2 WP4876,0.34853611657407885,2.797723292469352,2.948837895128255,['CASP1'],0.7453841700990201,0,0,1
197,Amplification and Expansion of Oncogenic Pathways as Metastatic Traits WP3678,0.34853611657407885,2.797723292469352,2.948837895128255,['NOTCH1'],0.7453841700990201,0,0,1
198,Cell Differentiation - Index WP2029,0.34853611657407885,2.797723292469352,2.948837895128255,['STAT3'],0.7453841700990201,0,0,1
199,Hedgehog Signaling Pathway Netpath WP47,0.34853611657407885,2.797723292469352,2.948837895128255,['ARNTL'],0.7453841700990201,0,0,1
200,Insulin signaling in adipocytes (diabetic condition) WP3635,0.34853611657407885,2.797723292469352,2.948837895128255,['TBC1D4'],0.7453841700990201,0,0,1
201,Insulin signaling in adipocytes (normal condition) WP3634,0.34853611657407885,2.797723292469352,2.948837895128255,['TBC1D4'],0.7453841700990201,0,0,1
202,Nanomaterial-induced inflammasome activation WP3890,0.34853611657407885,2.797723292469352,2.948837895128255,['CASP1'],0.7453841700990201,0,0,1
203,Nuclear receptors WP170,0.35231719936113265,1.722267206477733,1.7967094071276073,"['NR1D2', 'PPARD']",0.7497587690837897,0,0,2
204,Pathways in clear cell renal cell carcinoma WP4018,0.35899902313885224,1.3024486280300234,1.3342747567804474,"['LDHA', 'TPI1', 'STAT3', 'ALDOC', 'HIF1A']",0.7575898156618013,0,0,5
205,Amyotrophic lateral sclerosis (ALS) WP2447,0.361258106542433,1.460456942003515,1.486982636603193,"['CASP1', 'BAX', 'MAP2K6']",0.7575898156618013,0,0,3
206,Phosphodiesterases in neuronal function WP4222,0.361258106542433,1.460456942003515,1.486982636603193,"['PDE4D', 'PDE4B', 'GRIN2B']",0.7575898156618013,0,0,3
207,Proximal tubule transport WP4917,0.3828316731880637,1.5989974937343359,1.5352932449030685,"['SLC7A8', 'ATP6V1F']",0.7677645057118789,0,0,2
208,Unfolded protein response WP4925,0.3828316731880637,1.5989974937343359,1.5352932449030685,"['XBP1', 'HSPA5']",0.7677645057118789,0,0,2
209,Androgen receptor signaling pathway WP138,0.38550097865091426,1.221779633793768,1.164614455223007,"['CDKN1A', 'LIMK2', 'STAT3', 'DSTN', 'STUB1', 'RHOB']",0.7677645057118789,0,0,6
210,Small cell lung cancer WP4658,0.3999377008953933,1.279476861167002,1.1725720807117783,"['CDKN1A', 'CYCS', 'BAX', 'E2F3']",0.7677645057118789,0,0,4
211,15q13.3 copy number variation syndrome WP4942,0.40206818771408764,2.237828371278459,2.0389605833327233,['OTUD7A'],0.7677645057118789,0,0,1
212,ApoE and miR-146 in inflammation and atherosclerosis WP3926,0.40206818771408764,2.237828371278459,2.0389605833327233,['TLR2'],0.7677645057118789,0,0,1
213,Bone morphogenic protein (BMP) signaling and regulation WP1425,0.40206818771408764,2.237828371278459,2.0389605833327233,['SMAD6'],0.7677645057118789,0,0,1
214,Cytokines and Inflammatory Response WP530,0.40206818771408764,2.237828371278459,2.0389605833327233,['IL15'],0.7677645057118789,0,0,1
215,Fatty acid transporters WP5061,0.40206818771408764,2.237828371278459,2.0389605833327233,['ACSL1'],0.7677645057118789,0,0,1
216,FOXP3 in COVID-19 WP5063,0.40206818771408764,2.237828371278459,2.0389605833327233,['STAT3'],0.7677645057118789,0,0,1
217,"GPCRs, Class C Metabotropic glutamate, pheromone WP501",0.40206818771408764,2.237828371278459,2.0389605833327233,['GRM7'],0.7677645057118789,0,0,1
218,ID signaling pathway WP53,0.40206818771408764,2.237828371278459,2.0389605833327233,['ID2'],0.7677645057118789,0,0,1
219,Kynurenine Pathway and links to Cellular Senescence WP5044,0.40206818771408764,2.237828371278459,2.0389605833327233,['CDKN1A'],0.7677645057118789,0,0,1
220,LDLRAD4 and what we know about it WP4904,0.40206818771408764,2.237828371278459,2.0389605833327233,['PMEPA1'],0.7677645057118789,0,0,1
221,Mevalonate arm of cholesterol biosynthesis pathway WP4190,0.40206818771408764,2.237828371278459,2.0389605833327233,['HMGCS1'],0.7677645057118789,0,0,1
222,Osteoclast Signaling WP12,0.40206818771408764,2.237828371278459,2.0389605833327233,['SPP1'],0.7677645057118789,0,0,1
223,Pilocytic astrocytoma WP2253,0.40206818771408764,2.237828371278459,2.0389605833327233,['GRB2'],0.7677645057118789,0,0,1
224,Platelet-mediated interactions with vascular and circulating cells WP4462,0.40206818771408764,2.237828371278459,2.0389605833327233,['TLR2'],0.7677645057118789,0,0,1
225,Selective expression of chemokine receptors during T-cell polarization WP4494,0.40206818771408764,2.237828371278459,2.0389605833327233,['IL4R'],0.7677645057118789,0,0,1
226,Urea cycle and metabolism of amino groups WP497,0.40206818771408764,2.237828371278459,2.0389605833327233,['OAT'],0.7677645057118789,0,0,1
227,Glucocorticoid Receptor Pathway WP2880,0.42979238807147924,1.2913343247262403,1.0904711513973762,"['ENC1', 'PDE4B', 'CPEB4']",0.7677645057118789,0,0,3
228,Signaling of Hepatocyte Growth Factor Receptor WP313,0.42979238807147924,1.2913343247262403,1.0904711513973762,"['PXN', 'STAT3', 'GRB2']",0.7677645057118789,0,0,3
229,Amino Acid metabolism WP3925,0.43792385041887755,1.2099352874000762,0.9990559580097897,"['LDHA', 'WARS', 'OAT', 'IDH1']",0.7677645057118789,0,0,4
230,Cardiac Hypertrophic Response WP2795,0.43792385041887755,1.2099352874000762,0.9990559580097897,"['HDAC4', 'IGF1', 'IKBKE', 'MAP2K6']",0.7677645057118789,0,0,4
231,MET in type 1 papillary renal cell carcinoma WP4205,0.43792385041887755,1.2099352874000762,0.9990559580097897,"['CDKN1A', 'STAT3', 'GRB2', 'JAK3']",0.7677645057118789,0,0,4
232,GABA receptor Signaling WP4159,0.4418536719167816,1.3986842105263158,1.1424124090845598,"['SLC6A1', 'GABRG2']",0.7677645057118789,0,0,2
233,IL17 signaling pathway WP2112,0.4418536719167816,1.3986842105263158,1.1424124090845598,"['CEBPB', 'STAT3']",0.7677645057118789,0,0,2
234,Nanoparticle-mediated activation of receptor signaling WP2643,0.4418536719167816,1.3986842105263158,1.1424124090845598,"['PXN', 'GRB2']",0.7677645057118789,0,0,2
235,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.4426534739494438,1.1658583186360965,0.9501372698860454,"['HDAC4', 'STAT3', 'IGF1', 'IKBKE', 'MAP2K6']",0.7677645057118789,0,0,5
236,Gastrin signaling pathway WP4659,0.44569384870154394,1.1382284242678324,0.9198285695389817,"['CDKN1A', 'PXN', 'STAT3', 'TCF4', 'GRB2', 'RHOB']",0.7677645057118789,0,0,6
237,Estrogen Receptor Pathway WP2881,0.4512084735816136,1.8645650904845301,1.4838690026865615,['STAT3'],0.7677645057118789,0,0,1
238,FOXA2 pathway WP5066,0.4512084735816136,1.8645650904845301,1.4838690026865615,['PPARGC1B'],0.7677645057118789,0,0,1
239,Galanin receptor pathway WP4970,0.4512084735816136,1.8645650904845301,1.4838690026865615,['CDKN1A'],0.7677645057118789,0,0,1
240,Hypertrophy Model WP516,0.4512084735816136,1.8645650904845301,1.4838690026865615,['IL18'],0.7677645057118789,0,0,1
241,Nanoparticle triggered regulated necrosis WP2513,0.4512084735816136,1.8645650904845301,1.4838690026865615,['FTL'],0.7677645057118789,0,0,1
242,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.4512084735816136,1.8645650904845301,1.4838690026865615,['MAD1L1'],0.7677645057118789,0,0,1
243,Interleukin-11 Signaling Pathway WP2332,0.4520805403386412,1.2433118531536809,0.9870589746797604,"['STAT1', 'STAT3', 'GRB2']",0.7677645057118789,0,0,3
244,Microglia Pathogen Phagocytosis Pathway WP3937,0.4520805403386412,1.2433118531536809,0.9870589746797604,"['C1QB', 'C1QA', 'FCER1G']",0.7677645057118789,0,0,3
245,PDGF Pathway WP2526,0.4520805403386412,1.2433118531536809,0.9870589746797604,"['STAT1', 'STAT3', 'GRB2']",0.7677645057118789,0,0,3
246,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.4520805403386412,1.2433118531536809,0.9870589746797604,"['IFNAR2', 'CXCL12', 'STAT1']",0.7677645057118789,0,0,3
247,AGE/RAGE pathway WP2324,0.456663996721308,1.177909562638992,0.9232542263569314,"['STAT1', 'STAT3', 'CYCS', 'HIF1A']",0.7677645057118789,0,0,4
248,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.4622257754405364,1.0830802727324815,0.8358150131696914,"['GRIP1', 'RAB3A', 'RPS6KA5', 'STAT1', 'STAT3', 'SPP1', 'GRB2', 'YBX1', 'GRIN2B']",0.7677645057118789,0,0,9
249,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.47017919787891593,1.316202270381837,0.9932607040780942,"['RAB3A', 'LITAF']",0.7677645057118789,0,0,2
250,Notch Signaling WP268,0.47017919787891593,1.316202270381837,0.9932607040780942,"['NOTCH1', 'RBPJ']",0.7677645057118789,0,0,2
251,Type II interferon signaling (IFNG) WP619,0.47017919787891593,1.316202270381837,0.9932607040780942,"['OAS1', 'STAT1']",0.7677645057118789,0,0,2
252,Cytosolic DNA-sensing pathway WP4655,0.4740016759040705,1.1987195581220185,0.8948973992156285,"['CASP1', 'IL18', 'IKBKE']",0.7677645057118789,0,0,3
253,IL-6 signaling pathway WP364,0.4740016759040705,1.1987195581220185,0.8948973992156285,"['STAT1', 'STAT3', 'GRB2']",0.7677645057118789,0,0,3
254,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.4740016759040705,1.1987195581220185,0.8948973992156285,"['ATG3', 'ATG14', 'FTL']",0.7677645057118789,0,0,3
255,p53 transcriptional gene network WP4963,0.4740016759040705,1.1987195581220185,0.8948973992156285,"['CDKN1A', 'NOTCH1', 'BAX']",0.7677645057118789,0,0,3
256,Selenium Micronutrient Network WP15,0.4740016759040705,1.1987195581220185,0.8948973992156285,"['PRDX3', 'PRDX5', 'PLAT']",0.7677645057118789,0,0,3
257,Cell cycle WP179,0.4754820473138963,1.1188712522045856,0.8317981508356809,"['CDKN1A', 'E2F3', 'MAD1L1', 'YWHAG', 'YWHAH']",0.7677645057118789,0,0,5
258,Leptin signaling pathway WP2034,0.4754820473138963,1.1188712522045856,0.8317981508356809,"['PTPN1', 'STAT1', 'STAT3', 'BAX', 'GRB2']",0.7677645057118789,0,0,5
259,Pancreatic adenocarcinoma pathway WP4263,0.4754820473138963,1.1188712522045856,0.8317981508356809,"['CDKN1A', 'STAT1', 'STAT3', 'BAX', 'E2F3']",0.7677645057118789,0,0,5
260,Integrin-mediated Cell Adhesion WP185,0.4916613046663742,1.0967596915309334,0.7786612189034826,"['CAPNS1', 'PXN', 'ITGAX', 'GRB2', 'MAP2K6']",0.7677645057118789,0,0,5
261,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.493471715630113,1.1186619718309858,0.7900994682773113,"['NOTCH1', 'TBC1D4', 'GRB2', 'MGLL']",0.7677645057118789,0,0,4
262,IL-5 signaling pathway WP127,0.49551199751976627,1.157202593782195,0.8125456694215374,"['STAT1', 'STAT3', 'GRB2']",0.7677645057118789,0,0,3
263,BMP Signaling Pathway in Eyelid Development WP3927,0.496316697554058,1.5979484613460095,1.1194284975599895,['NOTCH1'],0.7677645057118789,0,0,1
264,Cytosine methylation WP3585,0.496316697554058,1.5979484613460095,1.1194284975599895,['IDH1'],0.7677645057118789,0,0,1
265,Eicosanoid metabolism via cyclooxygenases (COX) WP4719,0.496316697554058,1.5979484613460095,1.1194284975599895,['PPARD'],0.7677645057118789,0,0,1
266,ERK Pathway in Huntington's Disease WP3853,0.496316697554058,1.5979484613460095,1.1194284975599895,['RPS6KA5'],0.7677645057118789,0,0,1
267,Globo Sphingolipid Metabolism WP1424,0.496316697554058,1.5979484613460095,1.1194284975599895,['ST6GALNAC5'],0.7677645057118789,0,0,1
268,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.496316697554058,1.5979484613460095,1.1194284975599895,['ELOC'],0.7677645057118789,0,0,1
269,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.496316697554058,1.5979484613460095,1.1194284975599895,['UGCG'],0.7677645057118789,0,0,1
270,Mitochondrial LC-Fatty Acid Beta-Oxidation WP368,0.496316697554058,1.5979484613460095,1.1194284975599895,['ACSL1'],0.7677645057118789,0,0,1
271,"NAD metabolism, sirtuins and aging WP3630",0.496316697554058,1.5979484613460095,1.1194284975599895,['HIF1A'],0.7677645057118789,0,0,1
272,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.496316697554058,1.5979484613460095,1.1194284975599895,['IGF1'],0.7677645057118789,0,0,1
273,Ovarian infertility WP34,0.496316697554058,1.5979484613460095,1.1194284975599895,['CEBPB'],0.7677645057118789,0,0,1
274,Overview of nanoparticle effects WP3287,0.496316697554058,1.5979484613460095,1.1194284975599895,['BAX'],0.7677645057118789,0,0,1
275,Oxidation by Cytochrome P450 WP43,0.496316697554058,1.5979484613460095,1.1194284975599895,['CYP51A1'],0.7677645057118789,0,0,1
276,RalA downstream regulated genes WP2290,0.496316697554058,1.5979484613460095,1.1194284975599895,['YBX3'],0.7677645057118789,0,0,1
277,Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664,0.496316697554058,1.5979484613460095,1.1194284975599895,['TCF4'],0.7677645057118789,0,0,1
278,TFs regulate miRNAs related to cardiac hypertrophy WP1559,0.496316697554058,1.5979484613460095,1.1194284975599895,['STAT3'],0.7677645057118789,0,0,1
279,Nephrotic syndrome WP4758,0.49762514259103263,1.2428849902534114,0.8674196401738568,"['INF2', 'E2F3']",0.7677645057118789,0,0,2
280,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.49762514259103263,1.2428849902534114,0.8674196401738568,"['CALM3', 'CREB5']",0.7677645057118789,0,0,2
281,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.5165735405936308,1.1184534270650264,0.7387805625520851,"['CDKN1A', 'HSPA5', 'YBX3']",0.7802789144631066,0,0,3
282,DNA damage response WP707,0.5165735405936308,1.1184534270650264,0.7387805625520851,"['CDKN1A', 'CYCS', 'BAX']",0.7802789144631066,0,0,3
283,G13 Signaling Pathway WP524,0.5165735405936308,1.1184534270650264,0.7387805625520851,"['ARHGDIG', 'IQGAP1', 'PFN1']",0.7802789144631066,0,0,3
284,miRNA regulation of DNA damage response WP1530,0.5165735405936308,1.1184534270650264,0.7387805625520851,"['CDKN1A', 'CYCS', 'BAX']",0.7802789144631066,0,0,3
285,Pyrimidine metabolism WP4022,0.5165735405936308,1.1184534270650264,0.7387805625520851,"['DPYD', 'ENPP1', 'TYMP']",0.7802789144631066,0,0,3
286,Splicing factor NOVA regulated synaptic proteins WP4148,0.5165735405936308,1.1184534270650264,0.7387805625520851,"['EPB41L3', 'GRIN2B', 'GABRG2']",0.7802789144631066,0,0,3
287,Insulin Signaling WP481,0.5211618469698053,1.0270054735926342,0.6692939610501548,"['SNAP25', 'PTPN1', 'XBP1', 'RPS6KA5', 'TBC1D4', 'ENPP1', 'MAP3K8', 'GRB2', 'MAP2K6']",0.7821427872087714,0,0,9
288,Melatonin metabolism and effects WP3298,0.5241448111418369,1.1772853185595569,0.7605113356576423,"['PER3', 'ARNTL']",0.7821427872087714,0,0,2
289,1q21.1 copy number variation syndrome WP4905,0.5377231662060303,1.3979859894921192,0.8673264619872537,['GJA1'],0.7821427872087714,0,0,1
290,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.5377231662060303,1.3979859894921192,0.8673264619872537,['BAX'],0.7821427872087714,0,0,1
291,Leptin Insulin Overlap WP3935,0.5377231662060303,1.3979859894921192,0.8673264619872537,['STAT3'],0.7821427872087714,0,0,1
292,LTF danger signal response pathway WP4478,0.5377231662060303,1.3979859894921192,0.8673264619872537,['TLR2'],0.7821427872087714,0,0,1
293,miRNAs involved in DNA damage response WP1545,0.5377231662060303,1.3979859894921192,0.8673264619872537,['CDKN1A'],0.7821427872087714,0,0,1
294,Osteopontin Signaling WP1434,0.5377231662060303,1.3979859894921192,0.8673264619872537,['SPP1'],0.7821427872087714,0,0,1
295,Phytochemical activity on NRF2 transcriptional activation WP3,0.5377231662060303,1.3979859894921192,0.8673264619872537,['CEBPB'],0.7821427872087714,0,0,1
296,PPAR-alpha pathway WP2878,0.5377231662060303,1.3979859894921192,0.8673264619872537,['PLTP'],0.7821427872087714,0,0,1
297,Urea cycle and associated pathways WP4595,0.5377231662060303,1.3979859894921192,0.8673264619872537,['OAT'],0.7821427872087714,0,0,1
298,Autophagy WP4923,0.5497050737744811,1.1182456140350878,0.6691284011192407,"['ATG3', 'ATG14']",0.7889454879421124,0,0,2
299,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.5497050737744811,1.1182456140350878,0.6691284011192407,"['LY96', 'PLAT']",0.7889454879421124,0,0,2
300,miRNA regulation of prostate cancer signaling pathways WP3981,0.5497050737744811,1.1182456140350878,0.6691284011192407,"['CDKN1A', 'GRB2']",0.7889454879421124,0,0,2
301,Prion disease pathway WP3995,0.5497050737744811,1.1182456140350878,0.6691284011192407,"['HSPA5', 'STAT3']",0.7889454879421124,0,0,2
302,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.5572255038632407,1.0482205623901582,0.6129839410892064,"['CDKN1A', 'INF2', 'NOTCH1']",0.7970907869831787,0,0,3
303,B Cell Receptor Signaling Pathway WP23,0.5747339779087917,0.9861775098732072,0.5461924339480694,"['BCL6', 'HCLS1', 'GRB2', 'E2F3', 'PIK3AP1', 'MAP2K6']",0.7985990737112332,0,0,6
304,Autosomal recessive Osteopetrosis pathways WP4788,0.5757311709814111,1.2424596224946487,0.6859799040123651,['TCIRG1'],0.7985990737112332,0,0,1
305,Cancer immunotherapy by PD-1 blockade WP4585,0.5757311709814111,1.2424596224946487,0.6859799040123651,['STAT3'],0.7985990737112332,0,0,1
306,Gastric Cancer Network 1 WP2361,0.5757311709814111,1.2424596224946487,0.6859799040123651,['NOTCH1'],0.7985990737112332,0,0,1
307,Kallmann's Syndrome WP5074,0.5757311709814111,1.2424596224946487,0.6859799040123651,['GRB2'],0.7985990737112332,0,0,1
308,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.5757311709814111,1.2424596224946487,0.6859799040123651,['MAP2K6'],0.7985990737112332,0,0,1
309,Pathways of nucleic acid metabolism and innate immune sensing WP4705,0.5757311709814111,1.2424596224946487,0.6859799040123651,['OAS1'],0.7985990737112332,0,0,1
310,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.5757311709814111,1.2424596224946487,0.6859799040123651,['LDHA'],0.7985990737112332,0,0,1
311,Vitamin B12 metabolism WP1533,0.5757311709814111,1.2424596224946487,0.6859799040123651,['PLAT'],0.7985990737112332,0,0,1
312,Modulators of TCR signaling and T cell activation WP5072,0.5767659976803351,1.016296532992491,0.5592869306284797,"['RHOH', 'MAP3K8', 'GRB2']",0.7985990737112332,0,0,3
313,22q11.2 copy number variation syndrome WP4657,0.5957571475206652,0.9862503876770392,0.5108009365685058,"['OAT', 'EMC10', 'ARNTL']",0.812202752065491,0,0,3
314,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.5957571475206652,0.9862503876770392,0.5108009365685058,"['RPS6KA5', 'MAP3K8', 'MAP2K6']",0.812202752065491,0,0,3
315,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.596661123999407,0.971830985915493,0.5018593115339329,"['STAT3', 'BAX', 'GRB2', 'IGF1']",0.812202752065491,0,0,4
316,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.596661123999407,0.971830985915493,0.5018593115339329,"['STAT1', 'PDE4D', 'STAT3', 'MAP2K6']",0.812202752065491,0,0,4
317,Glycogen Synthesis and Degradation WP500,0.5978714702704309,1.016267942583732,0.5227473766507393,"['CALM3', 'PYGL']",0.812202752065491,0,0,2
318,MAPK Cascade WP422,0.5978714702704309,1.016267942583732,0.5227473766507393,"['GRB2', 'MAP2K6']",0.812202752065491,0,0,2
319,Angiogenesis WP1539,0.6106191943561384,1.1180385288966725,0.5515080176845046,['HIF1A'],0.8141589258081845,0,0,1
320,Imatinib and Chronic Myeloid Leukemia WP3640,0.6106191943561384,1.1180385288966725,0.5515080176845046,['PIM1'],0.8141589258081845,0,0,1
321,Mitochondrial Gene Expression WP391,0.6106191943561384,1.1180385288966725,0.5515080176845046,['PPARGC1B'],0.8141589258081845,0,0,1
322,Pre-implantation embryo WP3527,0.6106191943561384,1.1180385288966725,0.5515080176845046,['ZFP36'],0.8141589258081845,0,0,1
323,TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453,0.6106191943561384,1.1180385288966725,0.5515080176845046,['IDH1'],0.8141589258081845,0,0,1
324,Type II diabetes mellitus WP1584,0.6106191943561384,1.1180385288966725,0.5515080176845046,['CACNA1A'],0.8141589258081845,0,0,1
325,Retinoblastoma gene in cancer WP2446,0.6141848619497849,0.957921164951042,0.4669475978182489,"['CDKN1A', 'E2F3', 'SAP30']",0.8163934164994064,0,0,3
326,G1 to S cell cycle control WP45,0.6204630938992427,0.9719298245614035,0.4638915638184094,"['CDKN1A', 'E2F3']",0.822208762467708,0,0,2
327,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.632038778113327,0.9311657879320445,0.42722308070031506,"['RPS6KA5', 'PIM1', 'MAP2K6']",0.8295564157920388,0,0,3
328,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.6420634913518227,0.9312865497076024,0.412623347229673,"['BST2', 'MAP2K6']",0.8295564157920388,0,0,2
329,"4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression WP3879",0.6426429355810604,1.0162394523165101,0.4493465531081715,['MAP2K6'],0.8295564157920388,0,0,1
330,Endothelin Pathways WP2197,0.6426429355810604,1.0162394523165101,0.4493465531081715,['RAMP1'],0.8295564157920388,0,0,1
331,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.6426429355810604,1.0162394523165101,0.4493465531081715,['PXN'],0.8295564157920388,0,0,1
332,PKC-gamma calcium signaling pathway in ataxia WP4760,0.6426429355810604,1.0162394523165101,0.4493465531081715,['CACNA1A'],0.8295564157920388,0,0,1
333,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.6426429355810604,1.0162394523165101,0.4493465531081715,['BAX'],0.8295564157920388,0,0,1
334,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.6426429355810604,1.0162394523165101,0.4493465531081715,['P3H2'],0.8295564157920388,0,0,1
335,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.6432902761350301,0.9118999712561081,0.402293076643851,"['HMGCS1', 'SCD', 'CYP51A1', 'PPARGC1B']",0.8295564157920388,0,0,4
336,Thermogenesis WP4321,0.6580223985004748,0.8935211267605634,0.3739531630577869,"['ACSL1', 'GRB2', 'MGLL', 'CREB5']",0.8415074151299033,0,0,4
337,CAMKK2  Pathway WP4874,0.6626828432119495,0.8938947368421053,0.36780082843534434,"['HDAC4', 'CHRM3']",0.8415074151299033,0,0,2
338,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.6626828432119495,0.8938947368421053,0.36780082843534434,"['XBP1', 'HSPA5']",0.8415074151299033,0,0,2
339,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.6626828432119495,0.8938947368421053,0.36780082843534434,"['STAT1', 'STAT3']",0.8415074151299033,0,0,2
340,Osteoblast differentiation WP4787,0.6660004518641491,0.8818795671075756,0.35845311648395567,"['NOTCH1', 'STAT1', 'RBPJ']",0.8415074151299033,0,0,3
341,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.6720371718051311,0.9314068884997081,0.37017986711766643,['BCL6'],0.8415074151299033,0,0,1
342,Folate Metabolism WP176,0.6720371718051311,0.9314068884997081,0.37017986711766643,['PLAT'],0.8415074151299033,0,0,1
343,Heart Development WP1591,0.6720371718051311,0.9314068884997081,0.37017986711766643,['NOTCH1'],0.8415074151299033,0,0,1
344,Interactome of polycomb repressive complex 2 (PRC2)  WP2916,0.6720371718051311,0.9314068884997081,0.37017986711766643,['ELL'],0.8415074151299033,0,0,1
345,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.6720371718051311,0.9314068884997081,0.37017986711766643,['RPS6KA5'],0.8415074151299033,0,0,1
346,Regulation of Actin Cytoskeleton WP51,0.6982165077735145,0.8583854308235934,0.3083544001899952,"['CHRM3', 'PXN', 'IQGAP1', 'PFN1', 'SSH2', 'FGF13']",0.8531005498213636,0,0,6
347,Cell migration and invasion through p75NTR WP4561,0.699017467149326,0.8596254883470295,0.3078143065674516,['STAT3'],0.8531005498213636,0,0,1
348,Ethanol effects on histone modifications WP3996,0.699017467149326,0.8596254883470295,0.3078143065674516,['HDAC4'],0.8531005498213636,0,0,1
349,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.699017467149326,0.8596254883470295,0.3078143065674516,['RAB27A'],0.8531005498213636,0,0,1
350,MTHFR deficiency WP4288,0.699017467149326,0.8596254883470295,0.3078143065674516,['CYCS'],0.8531005498213636,0,0,1
351,NRF2-ARE regulation WP4357,0.699017467149326,0.8596254883470295,0.3078143065674516,['CEBPB'],0.8531005498213636,0,0,1
352,Prostaglandin Synthesis and Regulation WP98,0.699017467149326,0.8596254883470295,0.3078143065674516,['PPARGC1B'],0.8531005498213636,0,0,1
353,"Relationship between inflammation, COX-2 and EGFR WP4483",0.699017467149326,0.8596254883470295,0.3078143065674516,['PTGES2'],0.8531005498213636,0,0,1
354,T-cell receptor (TCR) signaling pathway WP69,0.6997154552539632,0.8425458410842412,0.3008575488234548,"['CD83', 'MAP3K8', 'GRB2', 'OPRM1']",0.8531005498213636,0,0,4
355,Copper homeostasis WP3286,0.7010432758948706,0.8274204028589993,0.2938878613393939,"['STEAP3', 'XAF1']",0.8531005498213636,0,0,2
356,Kit receptor signaling pathway WP304,0.7125594986657879,0.8169660079729093,0.2768631327980374,"['STAT1', 'STAT3', 'GRB2']",0.8622568723350711,0,0,3
357,Pathways affected in adenoid cystic carcinoma WP3651,0.7125594986657879,0.8169660079729093,0.2768631327980374,"['CEBPA', 'NOTCH1', 'NFIB']",0.8622568723350711,0,0,3
358,Genotoxicity pathway WP4286,0.7188263083302775,0.7977443609022556,0.26336375291907904,"['CDKN1A', 'ID2']",0.8674105173147483,0,0,2
359,miRNA regulation of p53 pathway in prostate cancer WP3982,0.7237817425132121,0.7980985739304478,0.2579976488845422,['BAX'],0.8674872976794893,0,0,1
360,SARS-CoV-2 mitochondrial interactions WP5038,0.7237817425132121,0.7980985739304478,0.2579976488845422,['IKBKE'],0.8674872976794893,0,0,1
361,G Protein Signaling Pathways WP35,0.7254096207593596,0.811651728553137,0.2605554554165891,"['GNG10', 'GNG3', 'PDE4D', 'PDE4B']",0.8674872976794893,0,0,4
362,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.7269222262962387,0.7973889028370575,0.2543158565785175,"['CDKN1A', 'CYCS', 'BAX']",0.8674872976794893,0,0,3
363,Fragile X Syndrome  WP4549,0.7301659941391045,0.8262007590629499,0.2598264084725087,"['GRIP1', 'DUSP3', 'GRB2', 'SLC6A1', 'GRIN2B', 'GABRG2']",0.8689578773225707,0,0,6
364,16p11.2 distal deletion syndrome WP4950,0.7465117172851935,0.7447752481027438,0.2177305496822071,['GRB2'],0.8787276890114539,0,0,1
365,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.7465117172851935,0.7447752481027438,0.2177305496822071,['ATG3'],0.8787276890114539,0,0,1
366,Sphingolipid pathway WP1422,0.7465117172851935,0.7447752481027438,0.2177305496822071,['UGCG'],0.8787276890114539,0,0,1
367,Vitamin D in inflammatory diseases WP4482,0.7465117172851935,0.7447752481027438,0.2177305496822071,['MAP2K6'],0.8787276890114539,0,0,1
368,Energy Metabolism WP1541,0.7517239744569597,0.744327485380117,0.21242070154490478,"['PPARGC1B', 'PPARD']",0.8793253814494683,0,0,2
369,Metapathway biotransformation Phase I and II WP702,0.7517239744569597,0.744327485380117,0.21242070154490478,"['CYP51A1', 'SULT4A1']",0.8793253814494683,0,0,2
370,Oxidative phosphorylation WP623,0.7539534662548513,0.760904297811152,0.21489811380156912,"['NDUFA11', 'ATP5MC3', 'ATP5MC1']",0.8793253814494683,0,0,3
371,16p11.2 proximal deletion syndrome WP4949,0.7666410643438165,0.7438781487990627,0.1976756207857773,"['ASPHD1', 'MVP', 'MAP2K6']",0.8793253814494683,0,0,3
372,Regulation of Microtubule Cytoskeleton WP2038,0.7668949491785694,0.7202037351443124,0.1911459966024055,"['STAT3', 'TPPP']",0.8793253814494683,0,0,2
373,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.7668949491785694,0.7202037351443124,0.1911459966024055,"['CACNA1C', 'GRIN2B']",0.8793253814494683,0,0,2
374,Wnt Signaling Pathway WP363,0.7668949491785694,0.7202037351443124,0.1911459966024055,"['GJA1', 'TCF4']",0.8793253814494683,0,0,2
375,Alpha 6 Beta 4 signaling pathway WP244,0.7673742333482627,0.6981173380035026,0.18484798228429422,['GRB2'],0.8793253814494683,0,0,1
376,Intraflagellar transport proteins binding to dynein WP4532,0.7673742333482627,0.6981173380035026,0.18484798228429422,['DYNLT3'],0.8793253814494683,0,0,1
377,Physiological and pathological hypertrophy of the heart WP1528,0.7673742333482627,0.6981173380035026,0.18484798228429422,['STAT3'],0.8793253814494683,0,0,1
378,DNA damage response (only ATM dependent) WP710,0.7718150518161382,0.7561470518023394,0.19584989578652925,"['CDKN1A', 'BCL6', 'BAX', 'GRB2']",0.8820743449327293,0,0,4
379,Ebola Virus Pathway on Host WP4217,0.7789220179476561,0.7635717909690513,0.19077409279359872,"['BST2', 'STAT1', 'IQGAP1', 'IKBKE', 'RHOB']",0.8835120920938161,0,0,5
380,EGF/EGFR signaling pathway WP437,0.7800757841727685,0.7955927051671733,0.1975967495812609,"['GJA1', 'PLSCR1', 'RPS6KA5', 'STAT1', 'LIMK2', 'STAT3', 'GRB2', 'IQGAP1']",0.8835120920938161,0,0,8
381,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.7812537481014762,0.6975877192982456,0.1722032120322309,"['CXCL12', 'IKBKE']",0.8835120920938161,0,0,2
382,RANKL/RANK signaling pathway WP2018,0.7812537481014762,0.6975877192982456,0.1722032120322309,"['STAT1', 'MAP2K6']",0.8835120920938161,0,0,2
383,Aryl Hydrocarbon Receptor Pathway WP2873,0.7865224711981054,0.6569485937982898,0.15775568426585057,['BAX'],0.8846114338974869,0,0,1
384,TLR4 Signaling and Tolerance WP3851,0.7865224711981054,0.6569485937982898,0.15775568426585057,['IKBKE'],0.8846114338974869,0,0,1
385,Corticotropin-releasing hormone signaling pathway WP2355,0.7904166978806249,0.7119994017125977,0.16745870420607512,"['GJA1', 'IL18', 'TCF4']",0.8846114338974869,0,0,3
386,Glioblastoma signaling pathways WP2261,0.7904166978806249,0.7119994017125977,0.16745870420607512,"['CDKN1A', 'GRB2', 'MAP2K6']",0.8846114338974869,0,0,3
387,Hippo-Merlin Signaling Dysregulation WP4541,0.8015301014738637,0.6970562390158173,0.1542116695081574,"['ITGAX', 'CDH12', 'CDH18']",0.8900726755483545,0,0,3
388,Circadian rhythm related genes WP3594,0.803434366616348,0.7509826497796482,0.1643598986421212,"['PER3', 'DBP', 'ID2', 'NR1D2', 'NR1D1', 'ARNTL']",0.8900726755483545,0,0,6
389,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.8040970668204067,0.6203541545047675,0.1352590962520361,['BAX'],0.8900726755483545,0,0,1
390,Signal transduction through IL1R WP4496,0.8040970668204067,0.6203541545047675,0.1352590962520361,['MAP2K6'],0.8900726755483545,0,0,1
391,AMP-activated protein kinase (AMPK) signaling WP1403,0.8076585389235069,0.6563467492260062,0.1402061081927937,"['CDKN1A', 'PPARGC1B']",0.8900726755483545,0,0,2
392,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.8076585389235069,0.6563467492260062,0.1402061081927937,"['STAT1', 'TLR2']",0.8900726755483545,0,0,2
393,Rett syndrome causing genes WP4312,0.8197671680669348,0.6374937343358396,0.1266922665644215,"['TCF4', 'GRIN2B']",0.8925393534461767,0,0,2
394,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.8197671680669348,0.6374937343358396,0.1266922665644215,"['MAP3K8', 'GRB2']",0.8925393534461767,0,0,2
395,ATM Signaling Pathway WP2516,0.820227137310491,0.5876117614526685,0.11644936167356469,['CDKN1A'],0.8925393534461767,0,0,1
396,Glycerophospholipid Biosynthetic Pathway WP2533,0.820227137310491,0.5876117614526685,0.11644936167356469,['PGS1'],0.8925393534461767,0,0,1
397,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.820227137310491,0.5876117614526685,0.11644936167356469,['VMP1'],0.8925393534461767,0,0,1
398,VEGFA-VEGFR2 Signaling Pathway WP3888,0.8233966982119447,0.8204487725248204,0.15942729148213494,"['HDAC4', 'PTPN1', 'STAT1', 'STAT3', 'PXN', 'IQGAP1', 'LDB2', 'PTPN14', 'INPP4B', 'GJA1', 'LDHA', 'RPS6KA5', 'PTPRZ1', 'CYCS', 'GRB2', 'ELOC', 'PFN1', 'HSPA1A', 'MAP2K6']",0.8937371196672365,0,0,19
399,Ras signaling WP4223,0.8265780121572307,0.726148409893993,0.13830293603137692,"['GNG10', 'GNG3', 'CALM3', 'GRB2', 'KSR2', 'GRIN2B']",0.8949416071476783,0,0,6
400,Prader-Willi and Angelman Syndrome WP3998,0.8350312226811407,0.5581436077057793,0.10062556910017009,['GABRG2'],0.901833720495632,0,0,1
401,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.8383865227902565,0.6959876543209876,0.12268594791327857,"['PTPN1', 'RPS6KA5', 'SCD', 'MAP3K8', 'MAP2K6']",0.9031994459984808,0,0,5
402,IL-3 signaling pathway WP286,0.8419532070247993,0.6028449502133713,0.10370792310794723,"['STAT3', 'GRB2']",0.904785535907247,0,0,2
403,Integrated breast cancer pathway WP1984,0.8527525560181742,0.6787972641631178,0.10812280619495959,"['STAT1', 'PKIA', 'BAX', 'SMAD6', 'BACH1']",0.9141168838705986,0,0,5
404,Aryl Hydrocarbon Receptor Netpath WP2586,0.8610878334884623,0.5072440694156981,0.07586279729275688,['CDKN1A'],0.9207671882846924,0,0,1
405,BDNF-TrkB Signaling WP3676,0.8725319922420856,0.4851138353765324,0.06614816188388194,['GRB2'],0.9261273234608868,0,0,1
406,Neural Crest Cell Migration during Development WP4564,0.8725319922420856,0.4851138353765324,0.06614816188388194,['STAT3'],0.9261273234608868,0,0,1
407,Target Of Rapamycin (TOR) Signaling WP1471,0.8725319922420856,0.4851138353765324,0.06614816188388194,['PRR5'],0.9261273234608868,0,0,1
408,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.8830348321719553,0.46482778750729714,0.05782022208388565,['IGF1'],0.9349780575938351,0,0,1
409,Nonalcoholic fatty liver disease WP4396,0.8883867770788196,0.6539181043442112,0.07738994627063517,"['VMP1', 'CEBPA', 'XBP1', 'NDUFA11', 'CYCS', 'BAX']",0.9378416230516472,0,0,6
410,Fas ligand pathway and stress induction of heat shock proteins WP314,0.8926736550682276,0.4461646234676007,0.0506549492822524,['CYCS'],0.9378416230516472,0,0,1
411,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.8926736550682276,0.4461646234676007,0.0506549492822524,['HDAC4'],0.9378416230516472,0,0,1
412,Wnt signaling pathway and pluripotency WP399,0.8944230293918487,0.5182374541003671,0.05782308423681626,"['LRRK2', 'PPARD']",0.9378416230516472,0,0,2
413,Head and Neck Squamous Cell Carcinoma WP4674,0.9014096334978131,0.5063795853269537,0.052559912891348634,"['CDKN1A', 'NOTCH1']",0.9407159216352459,0,0,2
414,Neural Crest Cell Migration in Cancer WP4565,0.901519424900444,0.4289370874309578,0.04446949031456687,['STAT3'],0.9407159216352459,0,0,1
415,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.9096372867001996,0.412985665174807,0.03911360183132906,['GRB2'],0.9455408171937791,0,0,1
416,Endoderm differentiation WP2853,0.9115551158579493,0.5384658994274052,0.049863675870315066,"['NOTCH1', 'STAT1', 'TCF4']",0.9455408171937791,0,0,3
417,Pathways Regulating Hippo Signaling WP4540,0.9141076387536394,0.4842105263157895,0.043485469448005944,"['CDH12', 'CDH18']",0.9455408171937791,0,0,2
418,ATM Signaling Network in Development and Disease  WP3878,0.9170870426022996,0.398173630222667,0.03446307848962871,['HDAC4'],0.9455408171937791,0,0,1
419,DNA IR-double strand breaks and cellular response via ATM WP3959,0.9170870426022996,0.398173630222667,0.03446307848962871,['BAX'],0.9455408171937791,0,0,1
420,TGF-beta Signaling Pathway WP366,0.922900930361927,0.5558098591549295,0.044594506208394856,"['CDKN1A', 'LIMK2', 'GRB2', 'MAP2K6']",0.9492695283722676,0,0,4
421,Focal Adhesion WP306,0.9481078603694144,0.5105229075603044,0.027204237462021844,"['PXN', 'SPP1', 'GRB2', 'IGF1']",0.9728802747733659,0,0,4
422,Joubert Syndrome WP4656,0.9546163064346828,0.3181886414811108,0.014778523650154068,['KIAA0586'],0.9772375459236562,0,0,1
423,ErbB signaling pathway WP673,0.9605414397945361,0.39008925823330254,0.015704273323406504,"['CDKN1A', 'GRB2']",0.980978491705058,0,0,2
424,DNA IR-damage and cellular response via ATR WP4016,0.9649530024804491,0.2929302239837773,0.0104505437892811,['BCL6'],0.9817580527009264,0,0,1
425,Mesodermal commitment pathway WP2857,0.9658499361062356,0.3767469521260779,0.01309075193149253,"['TCF4', 'SMAD6']",0.9817580527009264,0,0,2
426,Ciliopathies WP4803,0.9704684297478094,0.3642795513373598,0.010919792014689055,"['KIAA0586', 'CCDC65']",0.9841369991808772,0,0,2
427,IL-1 signaling pathway WP195,0.9729384238302139,0.27136816026654137,0.007444845358605407,['MAP2K6'],0.9843311454207316,0,0,1
428,Male infertility WP4673,0.9791066886896722,0.25274637796529215,0.005336655145716208,['ARNTL'],0.9876922394800759,0,0,1
429,Proteasome Degradation WP183,0.9808332655947974,0.24709087371083868,0.004781899662308377,['PSMD5'],0.9876922394800759,0,0,1
430,Ciliary landscape WP4352,0.990819832561916,0.4151251143732347,0.003828518288820049,"['CTSA', 'DOCK5', 'TBC1D4', 'DYNLT3', 'IQGAP1']",0.9932929237376915,0,0,5
431,Electron Transport Chain (OXPHOS system in mitochondria) WP111,0.9909936345623728,0.2878560036454773,0.002604281601653415,"['ATP5MC3', 'ATP5MC1']",0.9932929237376915,0,0,2
432,mRNA Processing WP411,0.9977272756261227,0.2326500461680517,0.0005293511933025346,"['SNRPG', 'YBX1']",0.9977272756261227,0,0,2
